Answer
Catridecacog (NovoThirteen) has limited pregnancy data showing no negative effects on the mother or foetus/newborn, but no studies investigating drug-associated risks in pregnant women or animal reproduction studies exist, so use during pregnancy may be considered only if clearly indicated.
Sources for this answer
- NovoThirteen 2500 IU powder and solvent for solution for injectionNovo Nordisk Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked